Associate Vice President, Clinical Services - Market Access Marketing

📋 Description

• • The Associate Vice President, Clinical Services leads clinical content development and provides strategic direction for a subset of teams and initiatives within the market access practice area at Precision AQ, LLC, a top payer marketing agency supporting global pharmaceutical and life sciences clients in demonstrating the value of medical treatments to payers, providers, patients, and policymakers.
• • Day-to-day responsibilities include overseeing content development for 5–7 assigned accounts, independently leading key department initiatives such as onboarding and innovation, mediating and resolving escalated stakeholder issues, acting as the medical lead in brand planning and tactical plans for assigned accounts and new business opportunities, ensuring Clinical Services SOPs are developed and maintained, allocating resources across accounts and workstreams, providing timely feedback and coaching to direct and indirect reports (supervising 6+ team members including at least 1 Senior Medical Director or 2+ Medical Directors), and promoting adherence to Precision AQ’s PRECISION Principles (Client Service, Purpose, Accountability, Mutual Respect, Collaboration).
• • Precision AQ is a leader in generating, analyzing, and communicating evidence of clinical, economic, and societal value to improve market access and support clients’ missions of improving patient care globally. The company operates as a remote-first organization within the United States and emphasizes scientific rigor, strategic thinking, and collaborative execution in healthcare communications.
• • In this role, the individual will develop deep expertise in pharmaceutical manufacturer strategies, managed markets, and healthcare business dynamics while mentoring team members, driving innovation in clinical content, influencing client strategy, and advancing leadership capabilities in a high-impact, client-facing role that directly contributes to market access success and improved patient outcomes.